Kamura T, Okamura T, Murakawa M, Tsuda H, Teshima T, Shibuya T, Harada M, Niho Y
First Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
J Clin Invest. 1992 Aug;90(2):315-9. doi: 10.1172/JCI115864.
A congenital deficiency of the coagulation Factor XIII A subunit (F XIII A) is a rare autosomal recessive disorder that is characterized by a life-long bleeding tendency complicated by a difficulty in healing. Thus far, no molecular genetic analysis of this disorder has been reported. In this study, we demonstrate the molecular abnormalities in a family with this disorder. We performed Northern blot analysis of peripheral blood monocytes obtained from the propositus and found a 4-kb single band of F XIII A mRNA whose size was identical with that of normal subjects. Exons II-XV, which encode all the amino acids, were individually amplified by a polymerase chain reaction (PCR). All PCR products from the propositus had lengths indistinguishable from those of the wild type on agarose gel, suggesting that this defect results from either a point mutation or a short deletion/insertion. The sequencing of F XIII A cDNA from the propositus revealed a deletion of the dinucleotide AG within the AGAG repeat at the position of 210 to 213. Concerning the genomic sequence, a deletion of dinucleotide AG was also demonstrated in the intron B-exon III boundary. This deletion appeared to cause a frameshift mutation making a new stop codon shortly thereafter, and leading to a deficiency of plasma F XIII A. The heterozygosity of the F XIII A deficiency in the patient's offspring was documented by the nucleotide sequences of their exon III.
凝血因子XIII A亚基(F XIII A)先天性缺乏是一种罕见的常染色体隐性疾病,其特征是终生出血倾向并伴有愈合困难。迄今为止,尚未见该疾病的分子遗传学分析报道。在本研究中,我们展示了一个患有该疾病的家系中的分子异常情况。我们对先证者外周血单核细胞进行了Northern印迹分析,发现F XIII A mRNA有一条4 kb的单带,其大小与正常受试者相同。编码所有氨基酸的外显子II - XV通过聚合酶链反应(PCR)分别进行扩增。先证者的所有PCR产物在琼脂糖凝胶上的长度与野生型无差异,提示该缺陷可能是由点突变或短缺失/插入所致。对先证者F XIII A cDNA进行测序,发现在210至213位的AGAG重复序列中缺失了二核苷酸AG。关于基因组序列,在内含子B - 外显子III边界也证实存在二核苷酸AG的缺失。这种缺失似乎导致了移码突变,随后很快产生一个新的终止密码子,从而导致血浆F XIII A缺乏。通过对患者后代外显子III的核苷酸序列分析,证实了F XIII A缺乏的杂合性。